TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11453894

Group type: EXPERIMENTAL
Intervention: Modified prescriptions
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Prescription only medicines (POM)
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: POM prescriptions for patients aged 40-65 years
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: POM modifications in respiratory domain
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: POM modifications in nervous system
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Non-printed prescriptions
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Prescriptions by specialists
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Prescriptions by other GP's
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Prescriptions by other prescribers (dentists, midwives)
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: GP without online access to pharmacy computer
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Non-printed prescriptions (multivariate analysis)
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: Overall correction of prescriptions in Dutch community pharmacies
Number of subjects: 2014
Study: 9550954

Group type: COMPARATOR
Intervention: Day care
Number of subjects: 118

Group type: COMPARATOR
Intervention: Inpatient care
Number of subjects: 118
Study: 7996373

Group type: EXPERIMENTAL
Intervention: 0.1 mg nebulized furosemide per kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.25 mg nebulized furosemide per kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.50 mg nebulized furosemide per kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.0 mg nebulized furosemide per kg
Number of subjects: 8
Study: 3292038

Group type: EXPERIMENTAL
Intervention: Hemoccult II fecal occult blood testing (rehydrated)
Number of subjects: 27700

Group type: EXPERIMENTAL
Intervention: Hemoccult II fecal occult blood testing (unhydrated)
Number of subjects: 27700

Group type: EXPERIMENTAL
Intervention: Hemoccult II fecal occult blood testing (test group)
Number of subjects: 27700

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27700

Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 27700
Study: 31554450

Group type: EXPERIMENTAL
Intervention: Group A (prelistening phase and listening sessions during 4 nonstress tests)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group B (listening sessions during 4 nonstress tests)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group C (4 nonstress tests without any listening)
Number of subjects: 30
Study: 31769342

Group type: EXPERIMENTAL
Intervention: Longitudinal program for enhancing role modelling (3 months of onsite and online sessions)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 31308252

Group type: EXPERIMENTAL
Intervention: SPEA (Small-protein Enrichment Assay)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SPEA
Number of subjects: 0
Study: 28161828

Group type: EXPERIMENTAL
Intervention: Cover group (I‐ILM folded upside‐down over the MH as a single layer)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fill group (I‐ILM folded within the MH in multiple layers)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cover group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fill group
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cover group (MH over 700 µm)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fill group (MH over 700 µm)
Number of subjects: 27
Study: 26026638

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (four cycles of five minutes of cuff-induced arm ischemia with three minutes of reperfusion applied 40 minutes before CECT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 22918704

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (gel) for 6 months
Number of subjects: 38
Study: 21193191

Group type: EXPERIMENTAL
Intervention: Adhexil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 32
Study: 18295761

Group type: EXPERIMENTAL
Intervention: 1-hour preincubation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-hour preincubation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-hour preincubation
Number of subjects: 0
Study: 16873324

Group type: EXPERIMENTAL
Intervention: Stabilizing splints (SS)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nonoccluding control splints (CS)
Number of subjects: 72
Study: 12640508

Group type: EXPERIMENTAL
Intervention: digoxin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: digoxin + enalapril
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 10701660

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 9117181

Group type: EXPERIMENTAL
Intervention: Spa therapy at Vichy (France) for 3 weeks
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual therapy (control group)
Number of subjects: 188
Study: 8439642

Group type: EXPERIMENTAL
Intervention: Calcium polycarbophil (6 g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 3704978

Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline started 30 minutes before exercise and continued throughout the 60 minute recovery period
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline started immediately after the end of exercise
Number of subjects: 5

Group type: COMPARATOR
Intervention: Fatiguing exercise without aminophylline
Number of subjects: 5
Study: 31324081

Group type: EXPERIMENTAL
Intervention: Vildagliptin-Metformin
Number of subjects: 215

Group type: COMPARATOR
Intervention: Glimepiride-Metformin
Number of subjects: 215
Study: 30263304

Group type: EXPERIMENTAL
Intervention: Oral GABA administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 25801797

Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa intravenous infusions at 60 U/kg every other week for 1.2-4.8 years
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa intravenous infusions
Number of subjects: 57
Study: 23801602

Group type: EXPERIMENTAL
Intervention: Telaprevir 750 mg every 8 hours for 15 days (T)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Telaprevir in combination with pegylated interferon alfa-2a and ribavirin for 15 days (TPR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Peg‐IFN/RBV plus placebo for 15 days (PR)
Number of subjects: 24
Study: 20585222

Group type: EXPERIMENTAL
Intervention: Relaxation and music (RM)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Patient teaching (PT)
Number of subjects: 517
Study: 18191342

Group type: EXPERIMENTAL
Intervention: Fetal electrocardiogram (STAN) added to continuous FHR monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous FHR monitoring with fetal scalp pH testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fetal oxymetry
Number of subjects: 0
Study: 16830214

Group type: EXPERIMENTAL
Intervention: IMPACT diet (immunonutrition)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard enteral nutrition (control diet)
Number of subjects: 60
Study: 12967863

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% + brimonidine 0.2%
Number of subjects: 32

Group type: COMPARATOR
Intervention: latanoprost 0.005% + placebo
Number of subjects: 32
Study: 10911670

Group type: EXPERIMENTAL
Intervention: Social skills training modules
Number of subjects: 42

Group type: COMPARATOR
Intervention: ACT program
Number of subjects: 42
Study: 8833716

Group type: EXPERIMENTAL
Intervention: Eccentric total work
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Concentric relative endurance
Number of subjects: 9
Study: 1350696

Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg in three doses)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg in three doses)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6610024

Group type: EXPERIMENTAL
Intervention: Visual stimulation at various repetition rates (1.0, 3.9, 7.8, 15.5, 33.1, and 61 Hz)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Visual stimulation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Visual deprivation
Number of subjects: 9
Study: 30425180

Group type: EXPERIMENTAL
Intervention: FOLFIRI
Number of subjects: 395

Group type: COMPARATOR
Intervention: FOLFOX
Number of subjects: 395
Study: 28933611

Group type: EXPERIMENTAL
Intervention: Medium-frequency (MG: 40Hz x 360s)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (CG: no extra training)
Number of subjects: 80
Study: 27488192

Group type: EXPERIMENTAL
Intervention: l-mequitazine 2.5 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: l-mequitazine 5.0 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: l-mequitazine 10 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: mequitazine 10 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 25056655

Group type: EXPERIMENTAL
Intervention: Yogurt containing polydextrose, L. acidophilus NCFM, and B. lactis HN019 (Treatment Group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unflavored yogurt (Control Group)
Number of subjects: 0
Study: 21647623

Group type: EXPERIMENTAL
Intervention: Culturally tailored lifestyle intervention (Health is Wealth)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 40
Study: 19181414

Group type: EXPERIMENTAL
Intervention: Behavioural medicine intervention
Number of subjects: 94
Study: 17440276

Group type: EXPERIMENTAL
Intervention: Bromfenac sodium 0.1% eye drops (group A)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo eye drops (normal saline; group B)
Number of subjects: 22
Study: 15862408

Group type: COMPARATOR
Intervention: 300 mg clopidogrel loading dose
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: 600 mg clopidogrel loading dose
Number of subjects: 190
Study: 16897237

Group type: EXPERIMENTAL
Intervention: Landiolol 0.2 mg x kg(‐1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Landiolol 0.1 mg x kg(‐1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 14
Study: 10586347

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (150 units)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 21
Study: 8560679

Group type: EXPERIMENTAL
Intervention: Bicalutamide (50 mg once daily) plus LHRH analogue (goserelin acetate 3.6 mg every 28 days or leuprolide acetate 7.5 mg every 28 days)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Flutamide (250 mg three times daily) plus LHRH analogue (goserelin acetate 3.6 mg every 28 days or leuprolide acetate 7.5 mg every 28 days)
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Bicalutamide (50 mg once daily)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Flutamide (250 mg three times daily)
Number of subjects: 813
Study: 1991673

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Felodipine (twice daily for 2 months)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Felodipine (1 year follow-up)
Number of subjects: 13
Study: 6641302

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of theophylline and terbutaline
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31053180

Group type: EXPERIMENTAL
Intervention: GSP301 (olopatadine 665 μg and mometasone 25 μg)
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: GSP301
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Olopatadine (665 μg)
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Mometasone (25 μg)
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1180
Study: 29522523

Group type: EXPERIMENTAL
Intervention: Rural Response System (RRS) intervention
Number of subjects: 2126
Study: 25487857

Group type: EXPERIMENTAL
Intervention: Narcissistic leadership qualities in unacquainted groups (Study 1)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Narcissistic leadership qualities in acquainted groups (Study 2)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Transformational leadership mediation in Study 1
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Transformational leadership mediation in Study 2
Number of subjects: 264
Study: 24556512

Group type: EXPERIMENTAL
Intervention: Sub-sheath block (n=16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Peri-sheath block (n=18)
Number of subjects: 34
Study: 22737864

Group type: EXPERIMENTAL
Intervention: Stronger neo-minophagen C 100 mL dissolved in 10% dextrose 250 ml once a day intravenously, combined with decoction of turtle shell for anti-fibrosis one powder daily
Number of subjects: 94

Group type: COMPARATOR
Intervention: Stronger neo-minophagen C alone
Number of subjects: 94
Study: 19940840

Group type: EXPERIMENTAL
Intervention: HB‐AS02 (three doses at 0, 1, and 6 months)
Number of subjects: 151

Group type: COMPARATOR
Intervention: HB‐AS04 (four doses at 0, 1, 2, and 6 months)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: HB‐AS02
Number of subjects: 151

Group type: COMPARATOR
Intervention: HB‐AS04
Number of subjects: 151
Study: 17973175

Group type: EXPERIMENTAL
Intervention: Registry-generated audit, feedback, and patient reminder intervention
Number of subjects: 483

Group type: COMPARATOR
Intervention: Usual clinic education
Number of subjects: 483
Study: 16014597

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 102

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 102
Study: 12406033

Group type: EXPERIMENTAL
Intervention: Glyburide/metformin 2.5 mg/500 mg
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Glyburide/metformin 5 mg/500 mg
Number of subjects: 639

Group type: COMPARATOR
Intervention: Glyburide 10 mg b.i.d.
Number of subjects: 639

Group type: COMPARATOR
Intervention: Metformin 500 mg
Number of subjects: 639
Study: 9925692

Group type: EXPERIMENTAL
Intervention: Registered Nurses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General Surgeons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gastroenterology Fellows
Number of subjects: 0

Group type: COMPARATOR
Intervention: All Providers
Number of subjects: 0
Study: 7779234

Group type: EXPERIMENTAL
Intervention: anatomically contoured mattress overlay
Number of subjects: 17

Group type: COMPARATOR
Intervention: standard hospital mattress
Number of subjects: 17
Study: 31243920

Group type: EXPERIMENTAL
Intervention: Anular closure device
Number of subjects: 50
Study: 28653583

Group type: EXPERIMENTAL
Intervention: Warm-humidified (WH) CO2 (36.7°C, 95% humidity)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cold-dry (CD) CO2 (room temperature, 0% humidity)
Number of subjects: 101
Study: 25850089

Group type: EXPERIMENTAL
Intervention: WALKBOT-assisted locomotor training (WLT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional locomotor training (CLT)
Number of subjects: 30
Study: 23023529

Group type: EXPERIMENTAL
Intervention: 2RT laser therapy
Number of subjects: 23
Study: 20136757

Group type: EXPERIMENTAL
Intervention: LIRE (six sets at 40% one repetition maximum)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: LIRE with VO
Number of subjects: 23

Group type: COMPARATOR
Intervention: Seated control (CON)
Number of subjects: 23
Study: 17569256

Group type: COMPARATOR
Intervention: HER-2/neu over-expression in androgen dependent prostate cancer (10%)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HER-2/neu over-expression in androgen independent prostate cancer (33%)
Number of subjects: 54

Group type: COMPARATOR
Intervention: HER-2/neu over-expression in Gleason score >7 group (14.29%)
Number of subjects: 54

Group type: COMPARATOR
Intervention: HER-2/neu over-expression in clinical stage > T2 group (34.62%)
Number of subjects: 54
Study: 15773839

Group type: EXPERIMENTAL
Intervention: Posterior partial fundoplication
Number of subjects: 24

Group type: COMPARATOR
Intervention: Anterior partial fundoplication
Number of subjects: 24
Study: 12635468

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Number of subjects: 14
Study: 10337458

Group type: EXPERIMENTAL
Intervention: Topical dimethindene maleate (DMM) gel
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 24
Study: 8975289

Group type: EXPERIMENTAL
Intervention: Reactive gastritis (RG) in diabetics
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Reactive gastritis (RG) in diabetics after excluding NSAIDs use or cholecystectomy
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) infection in diabetics with RG
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Autonomic neuropathy (AN) in diabetics with RG
Number of subjects: 152

Group type: COMPARATOR
Intervention: Helicobacter pylori (Hp) infection in diabetics with CAG
Number of subjects: 152

Group type: COMPARATOR
Intervention: Autonomic neuropathy (AN) in diabetics with CAG
Number of subjects: 152
Study: 2010305

Group type: EXPERIMENTAL
Intervention: Radioimmunoscintigraphy (RIS)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 59
Study: 7091037

Group type: EXPERIMENTAL
Intervention: Piperazine
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Piperazine and Metronidazole
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 30938895

Group type: EXPERIMENTAL
Intervention: IRA-LTC scale (self-developed structured questionnaire consisting of 31 items)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: IRA-LTC scale
Number of subjects: 458
Study: 29784004

Group type: EXPERIMENTAL
Intervention: Retrograde autologous priming (RAP)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Non-RAP (control group)
Number of subjects: 118
Study: 27381786

Group type: EXPERIMENTAL
Intervention: Lottery scratch cards included with the form
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: Prize draw for a tablet computer
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: No financial incentive
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: Telephone reminder calls
Number of subjects: 6795

Group type: COMPARATOR
Intervention: Control group (not offered colonoscopy)
Number of subjects: 6795

Group type: COMPARATOR
Intervention: Lottery scratch cards in control group
Number of subjects: 6795

Group type: COMPARATOR
Intervention: Prize draw in control group
Number of subjects: 6795
Study: 23754631

Group type: EXPERIMENTAL
Intervention: 1 g Spirulina (Arthrospira platensis) per day for 12 weeks
Number of subjects: 52
Study: 23405800

Group type: EXPERIMENTAL
Intervention: Erdi Biejia Decoction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19786668

Group type: EXPERIMENTAL
Intervention: GC (gemcitabine 1,000 mg/m(2) on days 1 and 8 and carboplatin AUC 4.5 for 21 days)
Number of subjects: 178

Group type: COMPARATOR
Intervention: M-CAVI (methotrexate 30 mg/m(2) on days 1, 15, and 22; carboplatin AUC 4.5 on day 1; and vinblastine 3 mg/m(2) on days 1, 15, and 22 for 28 days)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: GC
Number of subjects: 178

Group type: COMPARATOR
Intervention: M-CAVI
Number of subjects: 178
Study: 18329225

Group type: EXPERIMENTAL
Intervention: Standardized psychosocial protocol (Matrix model)
Number of subjects: 784

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 784
Study: 16202854

Group type: EXPERIMENTAL
Intervention: Felodipine + Metoprolol (F+M) 5 + 50 mg
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Enalapril (E) 10 mg
Number of subjects: 947

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 947
Study: 12374438

Group type: EXPERIMENTAL
Intervention: Talking while solving reasoning problems (Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beliefs about talking and thinking (Study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talking while solving reasoning problems (Study 3)
Number of subjects: 0
Study: 10021304

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (whole abdominal radiation 30 Gy over 4 weeks, additional 21.6 Gy to pelvis, 12 Gy to paraaortic region)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy only
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (specifically for stage III patients)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy only (specifically for stage III patients)
Number of subjects: 64
Study: 7498988

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (1.6 pmol/kg per minute) plus saline
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral candoxatril (200 mg) plus saline
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 11
Study: 2110033

Group type: EXPERIMENTAL
Intervention: Immediate invasive strategy
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Delayed invasive strategy
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Conservative strategy
Number of subjects: 586

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 586
Study: 111332

Group type: EXPERIMENTAL
Intervention: Group I: 40 Kcal/kg/day and 250 mg nitrogen/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group II: 30 Kcal/kg/day and 175 mg nitrogen/kg/24 hours
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group III: 20 Kcal/kg/day and 100 mg nitrogen/kg/24 hours
Number of subjects: 30
Study: 30897933

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 26